As of 2026-05-21, the Relative Valuation of Pfizer Inc (PFE) is 29.84 USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.79 USD, the upside of Pfizer Inc based on Relative Valuation is 15.7%.
The range of the Relative Valuation is 25.83 - 40.14 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.4x - 30.5x | 25.4x |
| Forward P/E multiples | 19.3x - 20.3x | 19.6x |
| Fair Price | 25.83 - 40.14 | 29.84 |
| Upside | 0.2% - 55.6% | 15.7% |
| Date | P/E |
| 2026-05-19 | 19.49 |
| 2026-05-18 | 19.23 |
| 2026-05-15 | 19.23 |
| 2026-05-14 | 19.55 |
| 2026-05-13 | 19.71 |
| 2026-05-12 | 19.64 |
| 2026-05-11 | 19.60 |
| 2026-05-08 | 19.50 |
| 2026-05-07 | 20.11 |
| 2026-05-06 | 20.15 |
| 2026-05-05 | 20.09 |
| 2026-05-04 | 19.97 |
| 2026-05-01 | 19.99 |
| 2026-04-30 | 20.27 |
| 2026-04-29 | 19.94 |
| 2026-04-28 | 20.11 |
| 2026-04-27 | 20.34 |
| 2026-04-24 | 20.50 |
| 2026-04-23 | 20.25 |
| 2026-04-22 | 20.35 |
| 2026-04-21 | 20.74 |
| 2026-04-20 | 20.90 |
| 2026-04-17 | 20.93 |
| 2026-04-16 | 20.67 |
| 2026-04-15 | 20.65 |
| 2026-04-14 | 20.59 |
| 2026-04-13 | 20.76 |
| 2026-04-10 | 20.44 |
| 2026-04-09 | 20.67 |
| 2026-04-08 | 20.86 |
| 2026-04-07 | 20.58 |
| 2026-04-06 | 21.13 |
| 2026-04-02 | 21.51 |
| 2026-04-01 | 21.68 |
| 2026-03-31 | 21.32 |
| 2026-03-30 | 21.09 |
| 2026-03-27 | 20.53 |
| 2026-03-26 | 20.94 |
| 2026-03-25 | 20.72 |
| 2026-03-24 | 20.47 |
| 2026-03-23 | 20.33 |
| 2026-03-20 | 20.48 |
| 2026-03-19 | 20.81 |
| 2026-03-18 | 20.75 |
| 2026-03-17 | 20.84 |
| 2026-03-16 | 20.21 |
| 2026-03-13 | 20.18 |
| 2026-03-12 | 20.40 |
| 2026-03-11 | 20.73 |
| 2026-03-10 | 20.62 |